Tarsus Pharmaceuticals, Inc. (TARS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $562.16M | +49.1% |
| 2024 | $376.99M | +42.0% |
| 2023 | $265.49M | +16.5% |
| 2022 | $227.86M | +27.4% |
| 2021 | $178.91M | +4.0% |
| 2020 | $171.97M | +194.9% |
| 2019 | $58.32M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $562.16M | +49.1% |
| 2024 | $376.99M | +42.0% |
| 2023 | $265.49M | +16.5% |
| 2022 | $227.86M | +27.4% |
| 2021 | $178.91M | +4.0% |
| 2020 | $171.97M | +194.9% |
| 2019 | $58.32M | — |